Venture Capital, Private Equity Funding
Maven Clinic Secures $90M to Advance End-to-End Family Care Platform
Maven Clinic, the largest virtual clinic in women’s and family health raises $90 million Series E funding bringing its total funding to $300M. Maven plans to use the latest round of funding to advance its end-to-end family care platform to enable deeper personalization to meet the diverse needs of women and families everywhere.
Curavit Raises $5M for Digital Therapeutics
Read More
Lux Capital
HLTH22: Maven Clinic Secures $90M to Advance End-to-End Family Care Platform
What You Should Know:
- Maven Clinic, the largest virtual clinic in women's and family health, today announced that it has raised a $90 million Series E funding round led by General Catalyst, with participation from CVS Health Ventures, La Famiglia, and Intermountain Ventures, as well as existing investors Sequoia, Oak HC/FT, Icon Ventures, Dragoneer Investment Group, and Lux Capital. This brings Maven's total funding to $300 million and highlights the growing demand for women's and family
Read More
Led by Sequoia, Benchling Raises $200M to Accelerate R&D Cloud Platform
- Today Benchling, the leading life and sciences R&D cloud, announced a $200M Series E raise led by Sequoia Capital Global Equities and joined by Altimeter Capital, Byers Capital, and Elad Gil. This funding will be used to aggressively invest in product development and global expansion to support enterprise customers. The raise is also joined by existing investors Thrive Capital, Benchmark, Menlo Ventures, Alkeon Capital, ICONIQ, Lux Capital, Spark Capital, and Lead Edge Capital.
-
Read More
H1 Secures $58M to Expand Global Healthcare Data Platform
What You Should Know:
- H1, the largest database of information on every doctor
in the world raises $58M in Series B funding, just six months after raising its
Series A round during the pandemic.
- H1 is the largest database in the world connecting that
provides comprehensive in-depth profiles of more than 9 million healthcare
professionals and 16,000 institutions in 70-plus countries, all of which are
kept up-to-date weekly.
H1, a global
platform for the healthcare
Read More
Everlywell Secures $175M to Expand Position in At-Home Testing Market
What You Should Know:
- Everlywell secures $175M in Series D funding to expand
its virtual care offerings, scale its testing and infrastructure, drive
clinical research and disease management through testing, and grow its national
leadership position in the at-home testing market.
- Since launching in 2016, more than one million people have used Everlywell's tests and digital platform to manage their health and wellness. As more people turn toward digital platforms for their health
Read More
Analysis: August Health IT M&A Activity; Public Company Performance
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of August 2020.
M&A is back and the velocity of the rebound has outpaced all expectations. The recovery quickly worked its way across the spectrum from large to small-cap, beginning with the larger cap NASDAQ rally of nearly 80% from lows in late March (only to soften in recent days), followed by multi-billion
Read More
Revenue Cycle Startup Rivet Lands $8.25M to Expand Price Transparency Platform
What You Need to Know:
- Revenue cycle management startup Rivet raises $8.25M Series A funding to expand its healthcare price transparency platform.
- The price transparency platform enables providers to give patients upfront pricing with the ability to pay prior to care via text while at the same time helping providers navigate the complex process that grants “in-network” status with insurance companies.
Rivet, a Salt Lake City, UT-based modern healthcare revenue cycle management
Read More
Bioelectronic Medicine Startup Cala Health Nabs $50M for Wearable Neuromodulation Therapies
Cala Health, Inc., a San Francisco, CA-based bioelectronic medicine company developing wearable therapies for chronic disease has raised $50 million in Series C funding. New investors in the Series C funding round include Novartis, Baird Capital, LifeSci Venture Partners, TriVentures, and others. All existing investors participated in the round, including Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Lux Capital, Lightstone Ventures, Action Potential Venture Capital, dRx Capital, and
Read More
Science 37 Raises $31M to Expand Virtual Clinical Trail Model
Science 37, Inc., a LosAngeles-based mobile technology and clinical trial startup that focuses on the development of networked patient-centric models for clinical research has raised $31 million in Series B funding led by Redmile Group. The Series B round also includes participation from Series A lead investors Lux Capital and dRx Capital, as well as a strategic investment from Sanofi Genzyme BioVentures. As part of the strategic investment, Sanofi’s international clinical trial development
Read More
